Spok Holdings Inc Cash Flow Conversion Efficiency

Latest as of March 2026: 0.017x

Spok Holdings Inc cash flow conversion efficiency. Based on the latest financial reports, Spok Holdings Inc (SPOK) has a cash flow conversion efficiency ratio of 0.017x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($2.44 Million) by net assets ($140.96 Million). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Spok Holdings Inc (2000–2025)

Cash flow conversion efficiency of Spok Holdings Inc from 2000 to 2025. This chart illustrates how Spok Holdings Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View SPOK stock price and chart for real-time trading data and today's change.

Spok Holdings Inc Cash Flow Conversion Ratio Explained

Spok Holdings Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Spok Holdings Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Spok Holdings Inc ranked by their cash flow conversion efficiency. Also see market cap of Spok Holdings Inc for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Ananti Inc
KQ:025980
0.009x
Zhejiang Renzhi Co Ltd
SHE:002629
-0.045x
Nanning Baling Technology
SHE:002592
-0.008x
centrotherm international AG
F:CTNK
0.077x
Dong-A St
KO:170900
0.003x
AC IMMUNE SA SF-02
F:IMR
-0.469x
RF Capital Group Inc
TO:RCG
0.017x
Bonava AB (publ)
ST:BONAV-B
-0.102x

Annual Cash Flow Conversion Efficiency for Spok Holdings Inc (2000–2025)

The table below shows the annual cash flow conversion efficiency of Spok Holdings Inc from 2000 to 2025. Review Spok Holdings Inc (SPOK) FCF generation index to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $146.38 Million $28.95 Million 0.198x +5.81%
2024-12-31 $154.75 Million $28.92 Million 0.187x +16.90%
2023-12-31 $163.77 Million $26.18 Million 0.160x +326.15%
2022-12-31 $172.08 Million $6.46 Million 0.038x -18.22%
2021-12-31 $173.69 Million $7.97 Million 0.046x -64.82%
2020-12-31 $200.61 Million $26.16 Million 0.130x +178.94%
2019-12-31 $250.09 Million $11.69 Million 0.047x +24.45%
2018-12-31 $274.55 Million $10.31 Million 0.038x -29.83%
2017-12-31 $290.53 Million $15.56 Million 0.054x -53.96%
2016-12-31 $322.09 Million $37.46 Million 0.116x +2.06%
2015-12-31 $333.55 Million $38.01 Million 0.114x -23.48%
2014-12-31 $279.06 Million $41.56 Million 0.149x -20.32%
2013-12-31 $269.95 Million $50.46 Million 0.187x -35.52%
2012-12-31 $251.42 Million $72.88 Million 0.290x -11.24%
2011-12-31 $252.44 Million $82.44 Million 0.327x -26.04%
2010-12-31 $184.39 Million $81.42 Million 0.442x -31.16%
2009-12-31 $158.80 Million $101.86 Million 0.641x -14.87%
2008-12-31 $140.74 Million $106.04 Million 0.753x +146.29%
2007-12-31 $373.57 Million $114.28 Million 0.306x -1.11%
2006-12-31 $475.97 Million $147.24 Million 0.309x +18.40%
2005-12-31 $532.99 Million $139.25 Million 0.261x +33.38%
2004-12-31 $583.34 Million $114.27 Million 0.196x -64.74%
2003-12-31 $326.26 Million $181.25 Million 0.556x -69.30%
2002-12-31 $114.22 Million $206.66 Million 1.809x +6428.13%
2001-12-31 $-1.66 Billion $47.37 Million -0.029x +91.66%
2000-12-31 $-94.26 Million $32.33 Million -0.343x --

About Spok Holdings Inc

NASDAQ:SPOK USA Health Information Services
Market Cap
$252.11 Million
Market Cap Rank
#15880 Global
#3794 in USA
Share Price
$12.07
Change (1 day)
+0.58%
52-Week Range
$10.11 - $13.94
All Time High
$18.76
About

Spok Holdings, Inc., through its subsidiary, Spok, Inc., engages in the healthcare communication solutions in the United States, Europe, Canada, Australia, Asia, and the Middle East. Its products and services enhance workflows for clinicians and support administrative compliance. The company delivers clinical information to care teams when and where it matters to enhance patient outcomes; and pro… Read more